HROWL
Sign in
Harrow Health, Inc. 8.625% Senior Notes due 2026
Save
1.22B
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Pharmaceuticals
Industry
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business.
Similar securities
Based on sector and market capitalization
Report issue